News from NORD

Foundation Fighting Blindness Opens USH2A Natural History Study


 

The first patient has been enrolled in a four-year, 120-person study of the rate of disease progression and severity in people with mutations in the USH2A gene, a mutation that causes blindness and in some cases the loss of both vision and hearing. Additional information is available here.

Recommended Reading

Investigational Drug May Effectively Treat Wilson’s Disease
MDedge Neurology
Blood Test Accurately Detects GLUT1 Deficiency Syndrome
MDedge Neurology
Join the National Organization for Rare Disorders and the University of Massachusetts for Two Upcoming CME-Accredited Events
MDedge Neurology
Rare Disease Film Festival Is Planned
MDedge Neurology
NORD Outlines Recommendations for Health Care Reform in Letter to Congressional Leadership
MDedge Neurology
Alport Syndrome Research Funding Is Awarded
MDedge Neurology
Aplastic Anemia and MDS International Foundation Plans Regional Patient/Family Conference
MDedge Neurology
Global CMTC/OVM Conference to Take Place in The Netherlands
MDedge Neurology
Conan O’Brien to Host Congenital Hyperinsulinism International Event
MDedge Neurology
CurePSP International Research Symposium to Take Place in San Francisco
MDedge Neurology